Open access · CC-BY
via OpenAlex
Selective increase in subtelomeric DNA methylation: an epigenetic biomarker for malignant glioma
Samrat Roy Choudhury, Yi Cui, Jacob Milton, Jian Li, Joseph Irudayaraj
Clinical Epigenetics · 2015 · ▲ 24 citations
Abstract
BACKGROUND: Subtelomeric regions dynamically change their epigenetic pattern during development and progression of several malignancies and degenerative disorders. However, DNA methylation of human subtelomeres and their correlation to telomere(definition) length (TL) remain undetermined in glioma. RESULTS: Herein, we report on the selective changes in subtelomeric DNA methylation at the end of five chromosomes (Chr.) (7q, 8q. 18p, 21q, and XpYp) and ascertain their correlation with TL in patients with glioma. Subtelomeric methylation level was invariably higher in glioma patients compared to the control group, irrespective of their age and tumor grade. In particular, a significant increase in methylation was observed at the subtelomeric CpG sites of Chr. 8q, 21q, and XpYp in tissues, obtained from the brain tumor of glioma patients. In contrast, no significant change in methylation was observed at the subtelomere of Chr. 7q and 18p. Selective changes in the subtelomeric methylation level, however, did not show any significant correlation to the global TL. This observed phenomenon was validated in vitro by inducing demethylation in a glioblastoma cell line (SF-767) using 5-azacytidine (AZA) treatment. AZA treatment caused significant changes in the subtelomeric methylation pattern but did not alter the TL, which supports our hypothesis. CONCLUSIONS: DNA methylation level dramatically increased at the subtelomere of Chr.8q, 21q, and XpYp in malignant glioma, which could be used as an early epigenetic diagnostic biomarker of the disease. Alterations in subtelomeric methylation, however, have no effects on the TL.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s13148-015-0140-y
- Canonical
- link ↗
- Fetched
- 2026-11-05 MST
Cite this
APA
Choudhury, S.R., Cui, Y., Milton, J., Li, J., & Irudayaraj, J. (2015). Selective increase in subtelomeric DNA methylation: an epigenetic biomarker for malignant glioma. <em>Clinical Epigenetics</em>. https://doi.org/10.1186/s13148-015-0140-y
Vancouver
Choudhury SR, Cui Y, Milton J, Li J, Irudayaraj J. Selective increase in subtelomeric DNA methylation: an epigenetic biomarker for malignant glioma. Clinical Epigenetics. 2015. doi:10.1186/s13148-015-0140-y.
BibTeX
@article{samrat2015Select,
title = {Selective increase in subtelomeric DNA methylation: an epigenetic biomarker for malignant glioma},
author = {Samrat Roy Choudhury and Yi Cui and Jacob Milton and Jian Li and Joseph Irudayaraj},
journal = {Clinical Epigenetics},
year = {2015},
doi = {10.1186/s13148-015-0140-y},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2014
Open access · CC-BY
Gut Microbiomes of Indian Children of Varying Nutritional Status
The Egyptian Journal of Neurology Psychiatry and Neurosurgery 2020
Open access · CC-BY
Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
biorxiv 2025
Preprint · CC-BY
3BTRON: A Blood-Brain Barrier Recognition Network
Frontiers in Neuroscience 2017
Open access · CC-BY
Mitochondrial Bioenergetics Is Altered in Fibroblasts from Patients with Sporadic Alzheimer's Disease
Wiadomości Lekarskie 2023
Open access · OA
CHANGES IN SERUM SOMATOSTATIN AND GASTRIN LEVELS IN PATIENTS AFTER CHOLECYSTECTOMY AND GASTROESOPHAGEAL REFLUX DISEASE
Evidence-based Complementary and Alternative Medicine 2012
Open access · CC-BY